What is Evoke Pharma's official website?

Evoke Pharma's website is evokepharma.com

What is Evoke Pharma's industry?

Evoke Pharma's industry is Biotechnology Research

Who are Evoke Pharma's top competitors?

Evoke Pharma's top competitors are , , , , , ,

Evoke Pharma company information, Employees & Contact Information

Updated May 2026

Quick answer

Evoke Pharma is a Biotechnology Research company and founded in 2007. It has approximately 26 employees on record. Contact data was last refreshed in May 2026. Find Evoke Pharma's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Evoke Pharma email format Evoke Pharma management contacts

Related company profiles:

Evoke Pharma is a Biotechnology company located in 420 Stevens Avenue, Suite 230, Solana Beach, California, 92075 United States

Employees: 26
Founded: -
Address: 420 Stevens Ave, Solana Beach,california 92075,united States
Phone: 7604871255
Email: bt****@****oup.com
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: evokepharma.com
HQ: Solana Beach, California
Competitors: EVERSANA, Evofem Biosciences, Eli Lilly and Company, Soleno Therapeutics, Inc., Madrigal Pharmaceuticals, AbbVie, Enterra Medical, Inc., AstraZeneca, Intra-Cellular Therapies, Aytu BioPharma.

Evoke Pharma Questions

News

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro - GlobeNewswire

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro GlobeNewswire

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038 - Yahoo Finance

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038 Yahoo Finance

18-Year Patent Protection: Evoke Pharma's Gastroparesis Nasal Spray GIMOTI Gains FDA Orange Book Listing - Stock Titan

18-Year Patent Protection: Evoke Pharma's Gastroparesis Nasal Spray GIMOTI Gains FDA Orange Book Listing Stock Titan

Evoke Pharma Receives Patent Allowances Expanding Intellectual Property for GIMOTI® Nasal Spray Treatment for Gastroparesis - Quiver Quantitative

Evoke Pharma Receives Patent Allowances Expanding Intellectual Property for GIMOTI® Nasal Spray Treatment for Gastroparesis Quiver Quantitative

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Gastroparesis Drug Maker Evoke Posts Strong Growth as GIMOTI Adoption Accelerates - Stock Titan

Gastroparesis Drug Maker Evoke Posts Strong Growth as GIMOTI Adoption Accelerates Stock Titan

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments - Yahoo Finance

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments Yahoo Finance

Major Pharmacy Network Expansion: Evoke's GIMOTI Now Reaching 150+ GI Practice Locations via Omnicell Deal - Stock Titan

Major Pharmacy Network Expansion: Evoke's GIMOTI Now Reaching 150+ GI Practice Locations via Omnicell Deal Stock Titan

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK) - Yahoo Finance

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK) Yahoo Finance

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewswire

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 GlobeNewswire

Major Patent Win: GIMOTI Locks Down 6 More Years of Exclusivity for Revolutionary Gastroparesis Spray - Stock Titan

Major Patent Win: GIMOTI Locks Down 6 More Years of Exclusivity for Revolutionary Gastroparesis Spray Stock Titan

Evoke Pharma & EVERSANA Announce Statistically Significant - GlobeNewswire

Evoke Pharma & EVERSANA Announce Statistically Significant GlobeNewswire

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported Earnings, And Analysts Cut Their Target Price Yahoo Finance

Gastroparesis Treatment Market Size to Hit USD 10.45 Billion by 2034 - Precedence Research

Gastroparesis Treatment Market Size to Hit USD 10.45 Billion by 2034 Precedence Research

Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference - Stock Titan

Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference Stock Titan

Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti® - Yahoo Finance

Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti® Yahoo Finance

Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In - Stocktwits

Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In Stocktwits

FDA Approves Gimoti Nasal Spray for Diabetic Gastroparesis - Medical Professionals Reference

FDA Approves Gimoti Nasal Spray for Diabetic Gastroparesis Medical Professionals Reference

EVOK Stock Price and Chart — NASDAQ:EVOK - TradingView

EVOK Stock Price and Chart — NASDAQ:EVOK TradingView

Companies like Evoke Pharma

Top Evoke Pharma Employees

Kevin Radis

n/a

West Hartford, Connecticut, United States, United States

View

3
mckesson.com, aol.com, bauschhealth.com
Matt D'Onofrio

Ceo & Founder At Evoke Pharma, Inc

N/a

View
Vickie Reed

Independent Consultant, Board Member And Audit Chair

San Diego, California, United States, United States

View

2
mirati.com, san.rr.com

3 +185833XXXXX
Dave Gonyer

Ceo And Founder, Evoke Pharma

Cardiff-By-The-Sea, California, United States, United States

View

2
yahoo.com, evokepharma.com

9 +176043XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Evoke Pharma company information, Employees & Contact Information

Quick answer

Explore related pages

Company Details

Evoke Pharma Questions

What is Evoke Pharma's helpline number?

What is Evoke Pharma's official website?

What is Evoke Pharma's LinkedIn profile?

How many employees are working in Evoke Pharma right now?

What is Evoke Pharma's industry?

What are Evoke Pharma's top competitors?

What is Evoke Pharma's support email address?

What are Evoke Pharma's categories?

When was Evoke Pharma founded?

News

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro - GlobeNewswire

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038 - Yahoo Finance

18-Year Patent Protection: Evoke Pharma's Gastroparesis Nasal Spray GIMOTI Gains FDA Orange Book Listing - Stock Titan

Evoke Pharma Receives Patent Allowances Expanding Intellectual Property for GIMOTI® Nasal Spray Treatment for Gastroparesis - Quiver Quantitative

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Gastroparesis Drug Maker Evoke Posts Strong Growth as GIMOTI Adoption Accelerates - Stock Titan

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments - Yahoo Finance

Major Pharmacy Network Expansion: Evoke's GIMOTI Now Reaching 150+ GI Practice Locations via Omnicell Deal - Stock Titan

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK) - Yahoo Finance

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewswire

Major Patent Win: GIMOTI Locks Down 6 More Years of Exclusivity for Revolutionary Gastroparesis Spray - Stock Titan

Evoke Pharma & EVERSANA Announce Statistically Significant - GlobeNewswire

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Gastroparesis Treatment Market Size to Hit USD 10.45 Billion by 2034 - Precedence Research

Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference - Stock Titan

Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti® - Yahoo Finance

Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In - Stocktwits

FDA Approves Gimoti Nasal Spray for Diabetic Gastroparesis - Medical Professionals Reference

EVOK Stock Price and Chart — NASDAQ:EVOK - TradingView

Companies like Evoke Pharma

Astrazeneca

Eli Lilly And Company

Soleno Therapeutics,...

Enterra Medical, Inc.

Eversana

Madrigal Pharmaceuti...

Intra-Cellular Thera...

Aytu Biopharma

Evofem Biosciences

Abbvie

Top Evoke Pharma Employees

Kevin Radis

n/a

Matt D'Onofrio

Ceo & Founder At Evoke Pharma, Inc

Vickie Reed

Independent Consultant, Board Member And Audit Chair

Dave Gonyer

Ceo And Founder, Evoke Pharma

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data